(VIANEWS) – KMC PROPERTIES (KMCP.OL), NORWEGIAN AIR SHUT (NAS.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. KMC PROPERTIES (KMCP.OL)
46.4% sales growth and 9.14% return on equity
KMC Properties ASA, a real estate company, owns and operates industrial and logistics properties. It owns a portfolio of 44 properties in the Nordics and the Netherlands, as well as an office building in Moscow, Russia. The company was incorporated in 2020 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, KMC PROPERTIES has a trailing twelve months EPS of kr0.45.
PE Ratio
KMC PROPERTIES has a trailing twelve months price to earnings ratio of 12.98. Meaning, the purchaser of the share is investing kr12.98 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.14%.
Moving Average
KMC PROPERTIES’s value is under its 50-day moving average of kr5.97 and way below its 200-day moving average of kr6.81.
More news about KMC PROPERTIES.
2. NORWEGIAN AIR SHUT (NAS.OL)
10.5% sales growth and 26.91% return on equity
Norwegian Air Shuttle ASA, together with its subsidiaries, provides air travel services in Norway and internationally. It operates short haul point to point domestic and cross border flights services. It is also involved in aircraft financing, leasing, and ownership activities; and cargo activities. It operates a fleet of 70 aircrafts. Norwegian Air Shuttle ASA was founded in 1993 and is headquartered in Fornebu, Norway.
Earnings Per Share
As for profitability, NORWEGIAN AIR SHUT has a trailing twelve months EPS of kr0.95.
PE Ratio
NORWEGIAN AIR SHUT has a trailing twelve months price to earnings ratio of 12.6. Meaning, the purchaser of the share is investing kr12.6 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.91%.
Yearly Top and Bottom Value
NORWEGIAN AIR SHUT’s stock is valued at kr11.97 at 17:20 EST, way under its 52-week high of kr13.53 and way higher than its 52-week low of kr6.33.
Sales Growth
NORWEGIAN AIR SHUT’s sales growth is 43.6% for the ongoing quarter and 10.5% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
NORWEGIAN AIR SHUT’s EBITDA is 0.73.
More news about NORWEGIAN AIR SHUT.
3. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.76.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 22.44. Meaning, the purchaser of the share is investing kr22.44 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Moving Average
NAVAMEDIC’s value is above its 50-day moving average of kr38.73 and way above its 200-day moving average of kr35.15.
Sales Growth
NAVAMEDIC’s sales growth is 93.3% for the ongoing quarter and 9.6% for the next.
Volume
Today’s last reported volume for NAVAMEDIC is 2472 which is 86.32% below its average volume of 18083.
More news about NAVAMEDIC.
4. PERNOD RICARD (RI.PA)
7.9% sales growth and 14.84% return on equity
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. The company was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €9.46.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 21. Meaning, the purchaser of the share is investing €21 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.84%.
Volume
Today’s last reported volume for PERNOD RICARD is 59502 which is 87.04% below its average volume of 459378.
More news about PERNOD RICARD.
